about
Exogenous plant MIR168a specifically targets mammalian LDLRAP1: evidence of cross-kingdom regulation by microRNAEnhanced expression of ANGPTL2 in the microvascular lesions of diabetic glomerulopathyEvaluation of podocyte lesion in patients with diabetic nephropathy: Wilms' tumor-1 protein used as a podocyte marker.Lipoprotein glomerulopathy: clinical features and pathological characteristics in Chinese.Epidemiologic data of renal diseases from a single unit in China: analysis based on 13,519 renal biopsies.Obesity-related glomerulopathy: insights from gene expression profiles of the glomeruli derived from renal biopsy samples.Decreased platelet count in patients receiving continuous veno-venous hemofiltration: a single-center retrospective study.A non-invasive laboratory panel as a diagnostic and prognostic biomarker for thrombotic microangiopathy: development and application in a Chinese cohort study.Cardiac troponin I is abnormally expressed in non-small cell lung cancer tissues and human cancer cells.Initial transcatheter thrombolysis for acute superior mesenteric venous thrombosisMercury-induced membranous nephropathy: clinical and pathological features.Impact of continuous quality improvement initiatives on clinical outcomes in peritoneal dialysis.Comparison of double filtration plasmapheresis with immunoadsorption therapy in patients with anti-glomerular basement membrane nephritis.Obesity-related glomerulopathy: body mass index and proteinuria.The prevalence of immunologic injury in renal allograft recipients with de novo proteinuria.Glycogen synthase kinase 3β dictates podocyte motility and focal adhesion turnover by modulating paxillin activity: implications for the protective effect of low-dose lithium in podocytopathy.Malignant perivascular epithelioid cell tumor (PEComa) of cervix with TFE3 gene rearrangement: a case report.Picking transplant glomerulopathy out of the CAN: evidence from a clinico-pathological evaluationHeart-type fatty acid binding protein is associated with proteinuria in obesity.NSFC health research funding and burden of disease in ChinaRelationship between serum soluble urokinase plasminogen activator receptor level and steroid responsiveness in FSGSThe primary glomerulonephritides: a systems biology approach.Predominance of intraglomerular T-bet or GATA3 may determine mechanism of transplant rejection.The relationship between obesity and diabetic nephropathy in China.Using an isolated rat kidney model to identify kidney origin proteins in urine.The clinical features and outcomes of systemic AL amyloidosis: a cohort of 231 Chinese patients.Induction therapy with bortezomib and dexamethasone followed by autologous stem cell transplantation versus autologous stem cell transplantation alone in the treatment of renal AL amyloidosis: a randomized controlled trialGlomerular endothelial cell injury and cross talk in diabetic kidney diseaseGenome-wide screen of DNA methylation changes induced by low dose X-ray radiation in mice.Glycogen synthase kinase 3β orchestrates microtubule remodeling in compensatory glomerular adaptation to podocyte depletion.Renal involvement in non-Hodgkin lymphoma: proven by renal biopsy.Fluid overload at start of continuous renal replacement therapy is associated with poorer clinical condition and outcome: a prospective observational study on the combined use of bioimpedance vector analysis and serum N-terminal pro-B-type natriuretCirculating Mitochondrial DAMPs Are Not Effective Inducers of Proteinuria and Kidney Injury in RodentsACE-inhibition increases podocyte number in experimental glomerular disease independent of proliferation.Vascular calcification burden of Chinese patients with chronic kidney disease: methodology of a cohort study.Assessment of urinary kidney injury molecule-1 and interleukin-18 in the early post-burn period to predict acute kidney injury for various degrees of burn injury.Inhibition of glycogen synthase kinase-3β prevents NSAID-induced acute kidney injury.Expression of the EphA1 protein is associated with Fuhrman nuclear grade in clear cell renal cell carcinomas.De novo expression of podocyte proteins in parietal epithelial cells in experimental aging nephropathy.Role of Myeloid-Derived Suppressor Cells in Glucocorticoid-Mediated Amelioration of FSGS.
P50
Q24621515-AB58F027-5828-4A89-8ADB-81AB81F07FB1Q28292149-68E81668-81D8-4F6F-9DC2-6BA85E434168Q30963123-36047A0E-963F-47F1-9967-C11C48DFBA7BQ31122594-7876DB6A-6D26-40C4-AF03-93176A8A40D8Q33206211-71E44621-F03C-433A-9359-A48C44F5713CQ33224747-E0608AD8-C6D5-4F2B-ABC0-089FAEC0D911Q33415284-FD101DD2-BA1A-4E89-94D6-60FC5B5CDE1FQ33418553-2B38087B-1732-4A59-A576-57474F3938FBQ33582865-D19147E5-48CF-4422-A232-28A6BAF7B1EFQ33594949-7B748284-06A0-4CA3-A318-64820982E21AQ33684071-6B043BFF-CF8E-4C4E-88D6-BFED2AB52EEDQ33828188-437DC716-1F62-4012-8B3A-0F9B55A5C487Q34021733-3B6D11D1-5D2A-4FAD-9DA6-43A64C50F41AQ34075430-7E49E8E9-0DB5-424E-B1C4-01204D9AEBECQ34269169-E3C92204-DBD8-42E0-91EC-992988F7F8B9Q34302891-16A92A9B-E51B-4EA7-B704-07A19862450AQ34371874-DC195D58-B79C-41C8-AA8D-281940E1F63FQ34423734-ECF17564-599B-4434-B0F3-C2CAE15ED7EBQ34429806-C7470930-20DD-4822-9373-316F980F011FQ34450449-F72FEB18-221C-4C73-A6C2-DE9530955318Q34455143-134A1B4E-1108-4636-B131-94ADB36C5447Q34462626-C417928F-8693-4C0B-9E57-3AEAF270A17AQ34534855-1460A223-9C32-4BA4-8809-9610EB01EBB9Q34632532-4E1B4BB4-551E-4B68-8719-183032FC3AD4Q34794421-E16A88BD-5F1B-4014-B310-55E3F1128058Q35026460-3096E540-B2B3-4D4B-8549-7F0623A252EAQ35081363-E86CCA08-0F00-48BC-B4D8-FC4FB9C37AE0Q35086477-18E16790-A9BA-416E-A8D2-7D411BC497CCQ35116647-6ACF26A4-0061-4979-8243-6CA2C38B3F45Q35121215-C735F8CA-4CF7-4876-BE6D-FAF44513C4A1Q35147984-B6A87389-DB4B-4D42-BDC9-AB118B5C053CQ35342135-A08EC3A0-6289-4551-B606-2A608C28D9FCQ35527551-120EA8EA-AF22-4FEB-AA10-7E666D02C59BQ35547522-145C3C52-0B42-4C13-B94B-663B747A24B3Q35735968-8EA53231-FAC6-4A3B-A3A1-CFC42484C3F6Q35748320-0747FC9D-AA01-4F8D-B175-F79862FB6B0DQ35834731-A19F139C-3F3D-4B8E-9EDE-49F0D2C08278Q35919154-0CCEE449-D6C4-45D7-9FA4-4708ACFBDD93Q35964488-166AF273-4CD3-40F9-93C0-4D7D48F62D01Q36003095-CE47FB38-4733-44AD-A045-6CF102A7E5D6
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Zhi-hong Liu
@ast
Zhi-hong Liu
@en
Zhi-hong Liu
@es
Zhi-hong Liu
@nl
Zhi-hong Liu
@sl
type
label
Zhi-hong Liu
@ast
Zhi-hong Liu
@en
Zhi-hong Liu
@es
Zhi-hong Liu
@nl
Zhi-hong Liu
@sl
altLabel
Zhi-Hong Liu
@en
prefLabel
Zhi-hong Liu
@ast
Zhi-hong Liu
@en
Zhi-hong Liu
@es
Zhi-hong Liu
@nl
Zhi-hong Liu
@sl
P106
P31
P496
0000-0001-6093-0726